CXCL13/CXCR5 signaling axis in cancer
- 1 June 2019
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 227, 175-186
Abstract
No abstract availableKeywords
Funding Information
- The World Academy of Sciences
- Chinese Academy of Sciences
- University of Chinese Academy of Sciences
This publication has 149 references indexed in Scilit:
- Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer TreatmentMediators of Inflammation, 2014
- Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL)American Journal of Surgical Pathology, 2006
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005
- Role of the microenvironment in chronic lymphocytic leukaemiaBritish Journal of Haematology, 2003
- Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphomaOphthalmology, 2003
- Mechanisms of tumor evasion from the immune response2003
- CXCL13 (BCA‐1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cellsBritish Journal of Haematology, 2002
- CXCL13 Is Required for B1 Cell Homing, Natural Antibody Production, and Body Cavity ImmunityImmunity, 2002
- Follicular stromal cells and lymphocyte homing to folliclesImmunological Reviews, 2000
- BCA-1 is highly expressed in Helicobacter pylori–induced mucosa-associated lymphoid tissue and gastric lymphomaJournal of Clinical Investigation, 1999